Exodus Point Capital Management, LP Exelixis, Inc. Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$20.34 - $23.73 $1.15 Million - $1.34 Million	56,460 New	56,460 $1.27 Million
Q3 2023 Nov 09, 2023	SELL	$19.04 - $22.74 $7.18 Million - $8.57 Million	-377,043 Reduced 41.02%	542,211 $11.8 Million
Q2 2023 Aug 10, 2023	BUY	$18.17 - $20.48 $10.8 Million - $12.2 Million	597,075 Added 185.32%	919,254 $17.6 Million
Q1 2023 May 11, 2023	SELL	$16.3 - $19.41 $5.5 Million - $6.55 Million	-337,487 Reduced 51.16%	322,179 $6.25 Million
Q4 2022 Feb 13, 2023	BUY	$14.96 - $17.39 $1.82 Million - $2.11 Million	121,337 Added 22.54%	659,666 $10.6 Million
Q3 2022 Nov 10, 2022	BUY	$15.68 - $22.27 $7.66 Million - $10.9 Million	488,785 Added 986.57%	538,329 $8.44 Million
Q2 2022 Aug 19, 2022	BUY	$17.44 - $23.16 $864,047 - $1.15 Million	49,544 New	49,544 $1.03 Million
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $611,341 - $870,522	-34,058 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $699,210 - $858,942	34,058 New	34,058 $769,000
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $1.17 Million - $1.58 Million	-63,669 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.67 - $26.94 $138,551 - $180,578	6,703 Added 11.77%	63,669 $1.56 Million
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $937,660 - $1.56 Million	56,966 New	56,966 $1.35 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $189,375 - $236,125	-12,500 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$17.68 - $22.65 $221,000 - $283,125	12,500 New	12,500 $221,000
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $228,202 - $288,280	-11,643 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $158,926 - $253,817	11,643 New	11,643 $229,000

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.19 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.04 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$905 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$547 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$408 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account